0
CEO Fernando Andreu
"We are pioneers in a new category of tests for cancer therapy selection, focused on improving the outcomes of cancer treatment"
Interview:
https://www.analystgroup.se/textintervju/interview-with-2curex-ceo-fernando-andreu/
"We are pioneers in a new category of tests for cancer therapy selection, focused on improving the outcomes of cancer treatment"
Interview:
https://www.analystgroup.se/textintervju/interview-with-2curex-ceo-fernando-andreu/
